"Institución de atención oftalmológica de 3er nivel. Dedicada exclusivamente a la prevención, diagnóstico y tratamiento de todas las patologías oculares."

During the past decade, Centro Privado de Ojos Romagosa conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Privado de Ojos Romagosa" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Centro Privado de Ojos Romagosa" are "Geographic Atrophy" (2 trials), "Atrial Fibrillation" (1 trials), "Macular Degeneration" (1 trials) and "Myocardial Infarction" (1 trials). Many other conditions were trialed in "Centro Privado de Ojos Romagosa" in a lesser frequency.

Most popular intervention types in "Centro Privado de Ojos Romagosa" are "Drug" (3 trials), "Other" (3 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "No intervention" (2 trials), "Placebo" (2 trials), "Abicipar Pegol" (1 trials), "Empagliflozin" (1 trials) and "Omega 3 (n-3 PUFA)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro Privado de Ojos Romagosa" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Centro Privado de Ojos Romagosa". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Centro Privado de Ojos Romagosa, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Centro Privado de Ojos Romagosa, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".